Ubs Group Ag Vista Gen Therapeutics, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.12 - $0.3 $1,754 - $4,386
14,622 Added 8.01%
197,268 $23,000
Q4 2022

Feb 08, 2023
BUY
$0.09 - $4.8 $16,438 - $876,700
182,646 New
182,646 $18,000
Q2 2022

Aug 10, 2022
BUY
$0.88 - $1.73 $9,274 - $18,232
10,539 Added 81.56%
23,461 $21,000
Q1 2022

May 16, 2022
SELL
$1.14 - $2.09 $494,607 - $906,779
-433,866 Reduced 97.11%
12,922 $16,000
Q4 2021

Feb 14, 2022
BUY
$1.67 - $2.76 $390,063 - $644,655
233,571 Added 109.55%
446,788 $871,000
Q3 2021

Nov 15, 2021
BUY
$2.62 - $3.45 $557,973 - $734,736
212,967 Added 85186.8%
213,217 $585,000
Q2 2021

Aug 13, 2021
SELL
$1.96 - $3.15 $20,676 - $33,229
-10,549 Reduced 97.68%
250 $1,000
Q1 2021

May 12, 2021
SELL
$1.89 - $2.96 $17,578 - $27,530
-9,301 Reduced 46.27%
10,799 $23,000
Q4 2020

Feb 11, 2021
SELL
$0.65 - $1.94 $114 - $341
-176 Reduced 0.87%
20,100 $39,000
Q3 2020

Nov 12, 2020
SELL
$0.48 - $1.03 $27,477 - $58,962
-57,245 Reduced 73.84%
20,276 $14,000
Q2 2020

Jul 31, 2020
BUY
$0.37 - $0.61 $18,087 - $29,819
48,884 Added 170.7%
77,521 $41,000
Q1 2020

May 01, 2020
BUY
$0.32 - $0.8 $2,731 - $6,829
8,537 Added 42.47%
28,637 $13,000
Q4 2019

Feb 14, 2020
SELL
$0.3 - $1.41 $1,430 - $6,722
-4,768 Reduced 19.17%
20,100 $14,000
Q3 2019

Nov 14, 2019
BUY
$0.46 - $1.29 $4,311 - $12,089
9,372 Added 60.48%
24,868 $27,000
Q2 2019

Aug 14, 2019
BUY
$0.54 - $1.33 $8,367 - $20,609
15,496 New
15,496 $11,000
Q1 2019

May 14, 2019
SELL
$1.1 - $1.76 $9,189 - $14,703
-8,354 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$1.28 - $2.24 $3,504 - $6,133
-2,738 Reduced 24.68%
8,354 $13,000
Q3 2018

Nov 14, 2018
BUY
$1.23 - $1.49 $13,643 - $16,527
11,092 New
11,092 $16,000
Q2 2018

Aug 14, 2018
SELL
$0.85 - $1.5 $11,284 - $19,914
-13,276 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$0.91 - $1.73 $12,081 - $22,967
13,276 New
13,276 $12,000
Q4 2017

Feb 14, 2018
SELL
$0.72 - $2.03 $137 - $387
-191 Closed
0 $0
Q3 2017

Nov 14, 2017
SELL
$1.54 - $1.85 $9,079 - $10,907
-5,896 Reduced 96.86%
191 $0
Q2 2017

Aug 14, 2017
BUY
N/A
6,087
6,087 $11,000

Others Institutions Holding VTGN

# of Institutions
1
Shares Held
27.1K
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $517M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email